Stroke

Stroke Therapy Indicated Over Age 80

The  use of intravenous recombinant tissue plaminogen (rt-PA) to treat stroke was initially restricted to treatment in patients under the age of 80 and when started within 3 hours of symptom onset. Treatment with rt-PA can cause lysis of intravascular clots that cause...

The Real Stroke Risk is Not Treating Them

The FDA approved intravenous tissue plasminogen activator (tPA) for the treatment of patients with acute ischemic stroke more than 15 years ago. Dr. Mark Alberts writes in the current Journal of the American Medical Association (JAMA) that even though tPA is the only...